These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 26094771)

  • 41. Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis.
    Johansson L; Sherina N; Kharlamova N; Potempa B; Larsson B; Israelsson L; Potempa J; Rantapää-Dahlqvist S; Lundberg K
    Arthritis Res Ther; 2016 Sep; 18(1):201. PubMed ID: 27605245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Porphyromonas gingivalis peptidylarginine deiminase, a key contributor in the pathogenesis of experimental periodontal disease and experimental arthritis.
    Gully N; Bright R; Marino V; Marchant C; Cantley M; Haynes D; Butler C; Dashper S; Reynolds E; Bartold M
    PLoS One; 2014; 9(6):e100838. PubMed ID: 24959715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva.
    Harvey GP; Fitzsimmons TR; Dhamarpatni AA; Marchant C; Haynes DR; Bartold PM
    J Periodontal Res; 2013 Apr; 48(2):252-61. PubMed ID: 22978559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti-Cyclic Citrullinated Protein Antibody-Positive At-Risk Adults Without Arthritis.
    Mankia K; Cheng Z; Do T; Hunt L; Meade J; Kang J; Clerehugh V; Speirs A; Tugnait A; Hensor EMA; Nam JL; Devine DA; Emery P
    JAMA Netw Open; 2019 Jun; 2(6):e195394. PubMed ID: 31173126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology.
    Kharlamova N; Jiang X; Sherina N; Potempa B; Israelsson L; Quirke AM; Eriksson K; Yucel-Lindberg T; Venables PJ; Potempa J; Alfredsson L; Lundberg K
    Arthritis Rheumatol; 2016 Mar; 68(3):604-13. PubMed ID: 26554752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis.
    Cappelli LC; Konig MF; Gelber AC; Bingham CO; Darrah E
    Arthritis Res Ther; 2018 Mar; 20(1):59. PubMed ID: 29566742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association among periodontitis severity, anti-agalactosyl immunoglobulin G titer, and the disease activity of rheumatoid arthritis.
    Kaneko C; Kobayashi T; Ito S; Sugita N; Murasawa A; Ishikawa H; Tabeta K
    J Periodontal Res; 2021 Aug; 56(4):702-709. PubMed ID: 33641208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
    Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis.
    Mikuls TR; Payne JB; Reinhardt RA; Thiele GM; Maziarz E; Cannella AC; Holers VM; Kuhn KA; O'Dell JR
    Int Immunopharmacol; 2009 Jan; 9(1):38-42. PubMed ID: 18848647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis.
    Mikuls TR; Payne JB; Yu F; Thiele GM; Reynolds RJ; Cannon GW; Markt J; McGowan D; Kerr GS; Redman RS; Reimold A; Griffiths G; Beatty M; Gonzalez SM; Bergman DA; Hamilton BC; Erickson AR; Sokolove J; Robinson WH; Walker C; Chandad F; O'Dell JR
    Arthritis Rheumatol; 2014 May; 66(5):1090-100. PubMed ID: 24782175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Periodontal Disease in Individuals With a Genetic Risk of Developing Arthritis and Early Rheumatoid Arthritis: A Cross-Sectional Study.
    Bello-Gualtero JM; Lafaurie GI; Hoyos LX; Castillo DM; De-Avila J; Munevar JC; Unriza S; Londoño J; Valle-Oñate R; Romero-Sánchez C
    J Periodontol; 2016 Apr; 87(4):346-56. PubMed ID: 26609697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Role of Porphyromonas gingivalis in rheumatoid arthritis and inflammatory spondyloarthropathies].
    Białowąs K; Swierkot J; Radwan-Oczko M
    Postepy Hig Med Dosw (Online); 2014 Sep; 68():1171-9. PubMed ID: 25228525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Symptoms of periodontitis and antibody responses to Porphyromonas gingivalis in juvenile idiopathic arthritis.
    Lange L; Thiele GM; McCracken C; Wang G; Ponder LA; Angeles-Han ST; Rouster-Stevens KA; Hersh AO; Vogler LB; Bohnsack JF; Abramowicz S; Mikuls TR; Prahalad S
    Pediatr Rheumatol Online J; 2016 Feb; 14(1):8. PubMed ID: 26861944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.
    Wegner N; Lundberg K; Kinloch A; Fisher B; Malmström V; Feldmann M; Venables PJ
    Immunol Rev; 2010 Jan; 233(1):34-54. PubMed ID: 20192991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoantibodies against citrullinated histone H3 in rheumatoid arthritis and periodontitis patients.
    Janssen KMJ; de Smit MJ; Withaar C; Brouwer E; van Winkelhoff AJ; Vissink A; Westra J
    J Clin Periodontol; 2017 Jun; 44(6):577-584. PubMed ID: 28370244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure and mechanism of a bacterial host-protein citrullinating virulence factor, Porphyromonas gingivalis peptidylarginine deiminase.
    Goulas T; Mizgalska D; Garcia-Ferrer I; Kantyka T; Guevara T; Szmigielski B; Sroka A; Millán C; Usón I; Veillard F; Potempa B; Mydel P; Solà M; Potempa J; Gomis-Rüth FX
    Sci Rep; 2015 Jul; 5():11969. PubMed ID: 26132828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PPAD Activity Promotes Outer Membrane Vesicle Biogenesis and Surface Translocation by Porphyromonas gingivalis.
    Vermilyea DM; Moradali MF; Kim HM; Davey ME
    J Bacteriol; 2021 Jan; 203(4):. PubMed ID: 33257525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impacts of Porphyromonas gingivalis periodontitis on rheumatoid arthritis autoimmunity.
    Ahmadi P; Mahmoudi M; Kheder RK; Faraj TA; Mollazadeh S; Abdulabbas HS; Esmaeili SA
    Int Immunopharmacol; 2023 May; 118():109936. PubMed ID: 37098654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Porphyromonas gingivalis on citrullination of proteins by macrophages in vitro.
    Marchant C; Smith MD; Proudman S; Haynes DR; Bartold PM
    J Periodontol; 2013 Sep; 84(9):1272-80. PubMed ID: 23106505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.